Premium
Tryptase‐stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell Chemotaxis
Author(s) -
Berger Patrick,
Girodet Pierre-Olivier,
Begueret Hugues,
Ousova Olga,
Perng Diahn-Warng,
Marthan Roger,
Walls Andrew F.,
Lara J. Manuel Tu
Publication year - 2003
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.03-0041fje
Subject(s) - tryptase , chemotaxis , mast cell , cytokine , chemistry , microbiology and biotechnology , medicine , receptor , endocrinology , biology , immunology , biochemistry
Asthmatic patients have higher numbers of mast cells in the smooth muscle layer of airways than normal subjects. Human airway smooth muscle cells (HASMCs) are a source of various cytokines including transforming growth factor β1 (TGF‐β1), which is chemotactic for mast cells. We have thus examined the potential for interaction between HASMCs and mast cells and have investigated, in particular, the hypothesis that after stimulation, HASMCs can induce mast cell chemotaxis through the production of cytokines. Supernatants of HASMCs treated with the major mast cell product tryptase had increased chemotactic activity for the HMC‐1 mast cell line. The effect depended on an intact catalytic site for tryptase and could be induced by a peptide agonist for protease activated receptor 2. Chemotactic activity was related to the synthesis of TGF‐β1 by HASMCs and, to a lesser extent, to stem cell factor. The number of mast cells within the smooth muscle layer of asthmatic patients was closely related to TGF‐β1 expression by smooth muscle. HASMCs may thus be able to stimulate the accumulation of mast cells, and these cells may, in turn, stimulate the secretion of chemotactic factors by HASMCs.